111 related articles for article (PubMed ID: 19687316)
1. A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results.
Brock JE; Hornick JL; Richardson AL; Dillon DA; Lester SC
Am J Clin Pathol; 2009 Sep; 132(3):396-401. PubMed ID: 19687316
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
[TBL] [Abstract][Full Text] [Related]
3. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
[TBL] [Abstract][Full Text] [Related]
4. Comparison of anti-estrogen receptor antibodies SP1, 6F11, and 1D5 in breast cancer: lower 1D5 sensitivity but questionable clinical implications.
Bogina G; Zamboni G; Sapino A; Bortesi L; Marconi M; Lunardi G; Coati F; Massocco A; Molinaro L; Pegoraro C; Venturini M
Am J Clin Pathol; 2012 Nov; 138(5):697-702. PubMed ID: 23086770
[TBL] [Abstract][Full Text] [Related]
5. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
[TBL] [Abstract][Full Text] [Related]
6. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.
Hendricks JB; Wilkinson EJ
Mod Pathol; 1993 Nov; 6(6):765-70. PubMed ID: 7508117
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immunohistochemical analysis with estrogen receptor SP1 and 1D5 monoclonal antibodies in breast cancer.
Madeira KP; Daltoé RD; Sirtoli GM; Rezende LC; Carvalho AA; Guimarães Idos S; Silva IV; Rangel LB
Pathol Res Pract; 2012 Nov; 208(11):657-61. PubMed ID: 23017667
[TBL] [Abstract][Full Text] [Related]
10. Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies.
Gerdes J; Pickartz H; Brotherton J; Hammerstein J; Weitzel H; Stein H
Am J Pathol; 1987 Dec; 129(3):486-92. PubMed ID: 3501245
[TBL] [Abstract][Full Text] [Related]
11. Fixation time does not affect the expression of estrogen receptor.
Ibarra JA; Rogers LW; Kyshtoobayeva A; Bloom K
Am J Clin Pathol; 2010 May; 133(5):747-55. PubMed ID: 20395521
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
Gomez-Fernandez C; Mejias A; Walker G; Nadji M
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):137-41. PubMed ID: 19875957
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity.
Goldstein NS; Hunter S; Forbes S; Odish E; Tehrani M
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):203-7. PubMed ID: 17525635
[TBL] [Abstract][Full Text] [Related]
15. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
Kaufmann O; Köther S; Dietel M
Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
Pertschuk LP; Feldman JG; Kim YD; Braithwaite L; Schneider F; Braverman AS; Axiotis C
Cancer; 1996 Jun; 77(12):2514-9. PubMed ID: 8640700
[TBL] [Abstract][Full Text] [Related]
17. Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones.
Qiu J; Kulkarni S; Chandrasekhar R; Rees M; Hyde K; Wilding G; Tan D; Khoury T
Am J Clin Pathol; 2010 Nov; 134(5):813-9. PubMed ID: 20959666
[TBL] [Abstract][Full Text] [Related]
18. [Utility of the paraffin-embedded section method on the detection of estrogen receptor from breast cancer tissues--comparison of the paraffin-embedded section method (6F11 and 1D5) with frozen section (H222) and dextran-coated charcoal (DCC) ones].
Kawabata K; Watanabe K; Ozaki S; Ishiyama S
Rinsho Byori; 1999 Aug; 47(8):767-73. PubMed ID: 10511809
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of estrogen receptors in mammary carcinomas. Is immunocytochemical determination after formalin fixation sufficient?].
Haugen OA; Aasmundstad T; Johannesen E; Ytterhus B; Nervik I
Tidsskr Nor Laegeforen; 1993 Mar; 113(8):944-6. PubMed ID: 8470071
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
